| Lymphoplasmacytic Lymphoma studied in …STUDIED_INderived200 of 347show all (up to 200) |
|---|
| → studied in | NCT00923507recruiting Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05006716Phase 1/Phase 2 · recruiting A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728893Phase 2 · recruiting Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) · condition mapped PROBABILISTIC · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04840602Phase 2 · recruiting Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548450Phase 2 · not yet recruiting Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015896Phase 1/Phase 2 · completed Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039676active not recruiting Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101328Phase 1 · recruiting A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 ) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180724Phase 2 · active not recruiting An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326308recruiting Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387471Phase 2 · active not recruiting Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624906Phase 2 · active not recruiting Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06561347Phase 2 · recruiting Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791498Phase 2 · not yet recruiting Teclistamab In Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03521596completed Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04464200Phase 1 · active not recruiting 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441214active not recruiting Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval. · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03884998Phase 1 · active not recruiting Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05294731Phase 1/Phase 2 · recruiting Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766421Phase 3 · not yet recruiting Evaluation of Iopofosine I 131 vs. R-CD in WM Patients · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980116Phase 1 · recruiting Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06340737Phase 1 · recruiting AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169331Phase 4 · active not recruiting A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640102recruiting Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804686Phase 3 · recruiting A Long-term Extension Study of PCI-32765 (Ibrutinib) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06708897Phase 1 · recruiting A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07609862Phase 1/Phase 2 · recruiting A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01479842Phase 1 · active not recruiting Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024045Phase 1 · completed Study of Oral LOXO-338 in Patients With Advanced Blood Cancers · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711327not yet recruiting Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06043011recruiting Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04799275Phase 2/Phase 3 · active not recruiting Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07420959Phase 1/Phase 2 · not yet recruiting ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131022Phase 1 · recruiting A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339922Phase 2 · active not recruiting Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860880NA · recruiting Combating Cancer-Related Fatigue: A Personalized Supportive Care Program · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01209871Phase 1 · completed Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02332980Phase 2 · completed Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277729Phase 1/Phase 2 · active not recruiting A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04545762Phase 1 · recruiting Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07592481NA · not yet recruiting Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636175early Phase 1 · recruiting 64Cu-LLP2A for Imaging Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231952Phase 2 · recruiting A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03162536Phase 1/Phase 2 · active not recruiting A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06224309completed Preliminary Assessment of [18F]BL40 in PET/CT Scans · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734495Phase 2 · active not recruiting Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03820817Phase 1 · completed Rifaximin in Patients With Monoclonal Gammopathy · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Smoldering Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962636NA · terminated Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05190705Phase 2 · active not recruiting Loncastuximab Tesirine in WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246906Phase 2 · terminated Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01955499Phase 1 · active not recruiting Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362035Phase 1/Phase 2 · completed ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04263480Phase 2 · active not recruiting Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04273139Phase 2 · active not recruiting Ibrutinib + Venetoclax in Untreated WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269592recruiting Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177527active not recruiting Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03506373Phase 2 · terminated Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05099471Phase 2 · recruiting Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07249905Phase 1/Phase 2 · recruiting Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231412Phase 3 · completed Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03479268Phase 1 · active not recruiting Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05020678Phase 1 · active not recruiting NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03192397Phase 1/Phase 2 · active not recruiting Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544265Phase 1 · recruiting SynKIR-310 for Relapsed/Refractory B-NHL · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04488354Phase 1 · completed Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01813227Phase 2 · completed A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531 · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830137Phase 1 · recruiting A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02952508Phase 2 · active not recruiting Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07474961Phase 4 · not yet recruiting BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. · condition mapped PROBABILISTIC · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06510491Phase 2 · recruiting Epcoritamab in Previously Treated WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492050Phase 2 · active not recruiting Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464210Phase 2 · not yet recruiting Nemtabrutinib, Bortezomib, and Rituximab for WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151730recruiting Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05093153recruiting Spanish Registry of Patients With IgM Monoclonal Gammopathies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04775745Phase 1 · recruiting Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544019Phase 1 · recruiting Study of SGR-1505 in Mature B-Cell Neoplasms · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02844309Phase 4 · completed The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02844322Phase 4 · completed The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02844361Phase 4 · completed Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04463953Phase 2 · completed Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04883437Phase 2 · recruiting Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116437Phase 2 · completed Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740529Phase 1/Phase 2 · completed A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03674411Phase 2 · active not recruiting Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05952037Phase 2 · active not recruiting A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04191187Phase 2 · completed Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05602363Phase 1 · recruiting AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03620903Phase 2 · active not recruiting Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05065554Phase 2 · active not recruiting ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06986174Phase 2 · recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259122Phase 2 · not yet recruiting A Phase II Clinical Study of Zanubrutinib Combined With Four Cycles of CD20 Monoclonal Antibody and Reduced-Dose Bendamustine in the Treatment of Untreated Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02302469Phase 1/Phase 2 · completed Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830046completed Covid-19 Vaccine Responsiveness in MM and Waldenstrom · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06547866Phase 2 · not yet recruiting Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173790enrolling by invitation Watch and Wait or Worry and Wait in Indolent Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02153580Phase 1 · active not recruiting Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147885Phase 1/Phase 2 · active not recruiting Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565638NA · completed PROFAST Intervention in Precursor Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Smoldering Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169565Phase 1 · not yet recruiting Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04018248Phase 1 · completed BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04893564NA · recruiting Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07160270recruiting This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01198067Phase 1 · terminated Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04260217Phase 1 · completed APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722668Phase 2 · completed UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333486Phase 2 · terminated Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03133221Phase 2 · completed 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06550427recruiting Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing · condition mapped PROBABILISTIC · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04898647NA · recruiting Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04042376Phase 4 · completed A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04062448Phase 2 · completed A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942507NA · not yet recruiting Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04578600Phase 1 · completed CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072458Phase 1 · active not recruiting A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05281809Phase 2 · recruiting Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172700approved for marketing Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03410901Phase 1 · completed TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630042Phase 2 · completed Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03053440Phase 3 · completed A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM) · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03332173Phase 2 · completed Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM) · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04052854no longer available A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02298816withdrawn B-Cell Hematologic Malignancy Vaccination Registry · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05914662Phase 2 · unknown Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04274738Phase 1 · completed A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4 · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04450069Phase 1 · completed CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04279405Phase 1 · completed A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084650completed Optical Coherence Tomography (OCT) and OCT Angiography(OCTA) Deep Learning in Waldenström's Macroglobulinemia Patients · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01788020Phase 3 · completed Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04061512Phase 2/Phase 3 · recruiting Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03225716Phase 1 · terminated A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03329950Phase 1 · completed A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115059Phase 1 · terminated Dasatinib In Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03771157early Phase 1 · completed Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858568completed Immune Responses to COVID-19 Vaccination in Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769222Phase 1 · terminated Ipilimumab and Local Radiation for Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03833180Phase 1 · completed A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03679624Phase 2 · terminated Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02916979Phase 1 · completed Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697356Phase 2 · unknown R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661035Phase 2 · completed Allo HSCT Using RIC for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979948Phase 2 · unknown A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044745Phase 2 · terminated Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02962401Phase 2 · completed Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03010358Phase 1/Phase 2 · completed Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03364231Phase 2 · completed Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00783367Phase 2 · completed Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00644189Phase 1/Phase 2 · completed Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176691Phase 1 · withdrawn HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257242Phase 1 · completed Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02604511Phase 2 · completed Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01272817NA · completed Nonmyeloablative Allogeneic Transplant · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03187262Phase 2 · completed A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01647971Phase 1/Phase 2 · completed Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01416428Phase 1/Phase 2 · terminated Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03019666Phase 1 · completed Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04635683Phase 1 · withdrawn Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665115Phase 2 · withdrawn Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049541Phase 1 · completed Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01261247Phase 2 · completed Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744912Phase 1 · terminated Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02677324Phase 2 · completed Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003141Phase 1 · unknown PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01381692Phase 1/Phase 2 · completed Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma · condition mapped CURATED_BROADER · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01805037Phase 1/Phase 2 · terminated Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113802Phase 2 · terminated Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00546793Phase 1/Phase 2 · completed Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02640287NA · completed Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02933320Phase 1/Phase 2 · completed BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04952974unknown B-cell Chronic Lymphoid Malignancies Markers · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01592981Phase 2 · completed Randomised Trial in Waldenstrom's Macroglobulinaemia · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02669017Phase 1 · completed Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02037256NA · completed Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01046006Phase 2 · completed Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125293Phase 1/Phase 2 · terminated Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01678443Phase 1 · terminated Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02242045Phase 1 · completed Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL) · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02165397Phase 3 · completed Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936611Phase 2 · completed LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03601819Phase 1 · terminated Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702932not yet recruiting Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01474681Phase 1/Phase 2 · completed Safety and Tolerability of HSC835 in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02371148Phase 2 · completed Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258998Phase 2 · completed Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00422799Phase 2 · completed Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM) · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01075321Phase 1/Phase 2 · completed Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037645Phase 1/Phase 2 · terminated Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02991898Phase 2 · terminated Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · condition mapped ONTOLOGY_EXACT · 347 trials mapped (89 active) | — | — | Lymphoplasmacytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718419Phase 2 · completed A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma · condition mapped ALIAS · 347 trials mapped (89 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |